Wednesday, November 11, 2026

ACTA DIURNA

Seattle

Change city

Health · Seattle ·

Lila Bio receives $3.65 million NIH grant for research

Seattle startup Lila Bio received a $3.65 million NIH grant to develop an AI-designed protein treatment for pulmonary hypertension. The research is in lab and animal-testing stages.

1 report

In this story: Lila Bio, National Institutes of Health

Headline and summary written by the Acta Diurna desk using only what the outlets above reported. Read their reporting for the full story. How we stay neutral.